Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-15-000148
Filing Date
2015-01-21
Accepted
2015-01-21 15:35:32
Documents
1
Group Members
DOV YELINYAIR LAPIDOT

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk1516089.htm SC 13G/A 112031
  Complete submission text file 0001178913-15-000148.txt   113596
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Subject) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SC 13G/A | Act: 34 | File No.: 005-87280 | Film No.: 15538495
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 DIZENGOFF ST., DIZENGOFF CENTER GATE 3, TOP TOWER TEL AVIV L3 64332
Business Address 50 DIZENGOFF ST., DIZENGOFF CENTER GATE 3, TOP TOWER TEL AVIV L3 64332 972-3-713-2323
Yelin Lapidot Holdings Management Ltd. (Filed by) CIK: 0001590495 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A